Novanta (NOVT) Scheduled to Post Earnings on Tuesday

Novanta (NASDAQ:NOVT - Get Free Report) will be releasing its earnings data before the market opens on Tuesday, November 5th. Analysts expect Novanta to post earnings of $0.86 per share for the quarter. Investors interested in participating in the company's conference call can do so using this link.

Novanta (NASDAQ:NOVT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The technology company reported $0.73 EPS for the quarter, topping the consensus estimate of $0.69 by $0.04. Novanta had a net margin of 6.91% and a return on equity of 15.77%. The business had revenue of $235.86 million for the quarter, compared to analyst estimates of $233.63 million. During the same quarter in the previous year, the firm posted $0.80 earnings per share. Novanta's quarterly revenue was up 2.8% on a year-over-year basis. On average, analysts expect Novanta to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Novanta Stock Up 0.6 %

Shares of NASDAQ NOVT traded up $0.97 on Tuesday, reaching $177.22. 87,396 shares of the company's stock traded hands, compared to its average volume of 137,941. The business's 50 day simple moving average is $175.30 and its two-hundred day simple moving average is $169.00. Novanta has a 12 month low of $111.20 and a 12 month high of $187.12. The company has a market cap of $6.36 billion, a price-to-earnings ratio of 91.82 and a beta of 1.28. The company has a quick ratio of 1.73, a current ratio of 2.77 and a debt-to-equity ratio of 0.68.

Insider Activity at Novanta

In other Novanta news, CFO Robert Buckley sold 1,111 shares of Novanta stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $180.45, for a total value of $200,479.95. Following the completion of the transaction, the chief financial officer now directly owns 120,419 shares of the company's stock, valued at approximately $21,729,608.55. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last ninety days, insiders have sold 13,258 shares of company stock valued at $2,318,593. 1.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Separately, Robert W. Baird lifted their price objective on Novanta from $170.00 to $175.00 and gave the company a "neutral" rating in a research note on Wednesday, August 7th.

About Novanta

Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.